Literature DB >> 26268687

Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study.

Jue Liu1, Shikun Zhang2, Qiaomei Wang2, Haiping Shen2, Man Zhang3, Yiping Zhang2, Donghai Yan2, Min Liu4.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) infection is highly endemic (7-8% prevalence) in rural China, causing high mortality and societal burden. Data from men of reproductive age is scarce and last reported in 2006. We assessed the seroepidemiology of men in rural China, aiming to provide updated baseline data for the prevalence of HBV infection.
METHODS: We established prevalence of HBV infection from data gathered through a nationwide population-based study of Chinese rural men aged 21-49 years. Data were obtained from a physical check-up programme for couples of reproductive age, the National Free Preconception Health Examination Project, that covered 31 provinces from 2010-12. We tested serological samples with ELISA and categorised participants' HBV status based on presence of HBsAg, anti-HBV core antibody (anti-HBc), and anti-HBV surface antibody (anti-HBs).
FINDINGS: 2 030 083 men were recruited into the database from Jan 1, 2010, to Dec 31, 2012, and 1 966 013 men provided serum samples for analysis. 124 274 men (6%) tested positive for HBsAg, 178 559 (9%) tested positive for anti-HBc, and 583 923 (30%) tested positive for anti-HBs. Isolated anti-HBs (an indicator of vaccine-mediated immunity) were present in 527 566 men (27%). And 1 234 127 men (63%) were negative for all HBV makers (susceptible population). HBsAg prevalence was higher in men aged 25-39 years (6·35-6·47%) than in other age groups (5·54-5·78%; p<0·0001). HBV markers were all more prevalent in the eastern region of China than in the central or western regions (all p<0·0001). 32 326 (26%) of 124 274 HBsAg-positive men tested positive for HBeAg (suggesting high infectiousness); this decreased with increasing age (p<0·0001).
INTERPRETATION: HBV prevalence in men in rural China has changed from highly endemic into intermediate endemic in the past two decades. However, the absolute number of HBV-infected men and the susceptible population is still very large. FUNDING: Chinese Association of Maternal and Child Health Studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26268687     DOI: 10.1016/S1473-3099(15)00218-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  62 in total

1.  Comparison of anti-HBs persistence after hepatitis B vaccination on two-dose schedule and three-dose schedule among adults: results from a 12-year follow up study in China.

Authors:  Jingjing Lu; Bingyu Yan; Jiaye Liu; Wenlong Wu; Yi Feng; Aiqiang Xu; Li Zhang
Journal:  Hum Vaccin Immunother       Date:  2019-01-30       Impact factor: 3.452

2.  Prevalence of Underweight, Overweight, and Obesity Among Reproductive-Age Women and Adolescent Girls in Rural China.

Authors:  Yuan He; An Pan; Ying Yang; Yuanyuan Wang; Jihong Xu; Ya Zhang; Dujia Liu; Qiaomei Wang; Haiping Shen; Yiping Zhang; Donghai Yan; Zuoqi Peng; Frank B Hu; Xu Ma
Journal:  Am J Public Health       Date:  2016-12       Impact factor: 9.308

3.  Sero-epidemiology study of hepatitis B virus surface antibodies from 2017 to 2019 among Chinese young adults in Hunan Province: A three-year retrospective study.

Authors:  Ming Xie; Hongjiao Quan; Yuan Zeng; Shuqian Yuan; Yinyue Liu; Yide Yang
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 4.  Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review.

Authors:  Xinxin Bai; Lu Chen; Xinyao Liu; Yujia Tong; Lu Wang; Minru Zhou; Yanming Li; Guangyu Hu
Journal:  Vaccines (Basel)       Date:  2022-06-06

Review 5.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

6.  Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.

Authors:  Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Gong Yang; Wei Zhang; Xiao Ma; Yu-Ting Tan; Nathaniel Rothman; Yu-Tang Gao; Wong-Ho Chow; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2016-03-30       Impact factor: 7.396

7.  Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults.

Authors:  Juan Li; Fanyue Meng; Jingshan Zheng; Qi Liang; Huayu Li; Jingxin Li; Li Zhang; Jianhui Gan; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

8.  S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules.

Authors:  Jinsong Shao; Qineng Gong; Zeyu Yin; Wenjie Pan; Sanjeevi Pandiyan; Li Wang
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

9.  Clinical features of acute hepatitis E super-infections on chronic hepatitis B.

Authors:  Chong Chen; Shu-Ye Zhang; Dan-Dan Zhang; Xin-Yan Li; Yu-Ling Zhang; Wei-Xia Li; Jing-Jing Yan; Min Wang; Jing-Na Xun; Chuan Lu; Yun Ling; Yu-Xian Huang; Liang Chen
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

10.  The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population.

Authors:  Min Du; Shanshan Zhang; Lin Xiao; Yanyan Xu; Peiyi Liu; Yuhan Tang; Sheng Wei; Mingyou Xing; Xiaoping Miao; Ping Yao
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.